GOT2 and breast carcinoma: Interestingly, MTX, a classic chemotherapeutic drug for breast cancer treatment, was the top ranked drug positively correlated with GOT2 mRNA level among FDA approved drugs or those under clinical trials (Fig. 7A, Table S9).